T2 Biosystems Inc.

Citi’s government shutdown playbook: which stocks to avoid, how volatility may react, and the plan for gold

8:47 a.m. Today8:47 a.m. Sept. 29, 2023

- Jamie Chisholm

Gundlach says investors can sidestep carnage in stocks and earn 8% returns in bonds. Here’s how.

9:40 a.m. Sept. 26, 2023

- Barbara Kollmeyer

Nike’s no longer a buy after broker finds 9 in 10 with student debt worried about expenses

9:35 a.m. Sept. 25, 2023

- Barbara Kollmeyer

Bill Ackman says go short the long bond. Here’s why.

7:30 a.m. Sept. 22, 2023

- Jamie Chisholm

The economy is about to slow down. That’s the time for retail stocks, says Goldman Sachs.

9:37 a.m. Sept. 21, 2023

- Barbara Kollmeyer

T2 Biosystems reaches regulatory milestone that could be a game changer, analyst says

7:29 a.m. Sept. 21, 2023

- Ciara Linnane

T2 Biosystems’ stock extends losing streak despite FDA approval for anthrax and plague diagnostic test

4:50 p.m. Sept. 20, 2023

- James Rogers

Stick with Berkshire Hathaway, says this longtime investor, who’s wary of Nvidia and Tesla

9:40 a.m. Sept. 20, 2023

- Barbara Kollmeyer

‘We’re not in there for the next 20%, we’re in there for the next 300%.’ Two veteran managers on a neglected asset.

9:39 a.m. Sept. 19, 2023

- Barbara Kollmeyer

‘Emerging markets have a China problem.’ This strategist favors India, which just hit a record.

8:36 a.m. Sept. 14, 2023

- Steve Goldstein

Morgan Stanley says it’s a lonely bull, recommending government bonds

9:24 a.m. Sept. 11, 2023

- Steve Goldstein

What seven decades of yield-curve history tells us about the business cycle and the stock market, strategist says

8:40 a.m. Sept. 8, 2023

- Jamie Chisholm

Saudi Arabia as the new Switzerland? A new world order makes markets riskier, says JPMorgan strategist.

8:28 a.m. Sept. 6, 2023

- Steve Goldstein

Stocks and bonds are out of balance. Here’s what could come next.

8:27 a.m. Sept. 5, 2023

- Steve Goldstein

These stocks — the ‘beating heart’ of the economy — are in trouble, says strategist

9:32 a.m. Aug. 31, 2023

- Barbara Kollmeyer

Hedge funds have made a huge push into risky assets. Here’s what that means.

10:03 a.m. Aug. 30, 2023

- Barbara Kollmeyer

Lessons for next time after Nvidia’s stock didn’t surge, and options tanked, following blowout earnings

8:53 a.m. Aug. 28, 2023

- Steve Goldstein

Vanguard: Value stocks haven’t been this cheap to growth since the COVID outbreak

8:19 a.m. Aug. 25, 2023

- Jamie Chisholm

If markets sell off again, get ready to buy U.S. stocks, says HSBC

10:45 a.m. Aug. 23, 2023

- Barbara Kollmeyer

‘This is no longer a buy-the-dip market.’ Why this Goldman Sachs veteran is worried about the stock market.

9:30 a.m. Aug. 23, 2023

- Barbara Kollmeyer

10-K: T2 BIOSYSTEMS, INC.

4:40 p.m. March 31, 2023

- Edgar Online - (EDG = 10Q, 10K)

10-Q: T2 BIOSYSTEMS, INC.

6:46 p.m. Nov. 14, 2022

- Edgar Online - (EDG = 10Q, 10K)

T2 Biosystems, Inc. (TTOO) Q3 2022 Earnings Call Transcript

9:02 p.m. Nov. 10, 2022

- Seeking Alpha

T2 Biosystems, Inc. (TTOO) CEO John Sperzel on Q2 2022 Results - Earnings Call Transcript

11:00 p.m. Aug. 15, 2022

- Seeking Alpha